SG10201507001RA - Methods for the preparation of 5-[2-[7-(trifluoromethyl)-5-[4-(trifluoromethyl)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]ethynyl]-2-pyridinamine - Google Patents
Methods for the preparation of 5-[2-[7-(trifluoromethyl)-5-[4-(trifluoromethyl)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]ethynyl]-2-pyridinamineInfo
- Publication number
- SG10201507001RA SG10201507001RA SG10201507001RA SG10201507001RA SG10201507001RA SG 10201507001R A SG10201507001R A SG 10201507001RA SG 10201507001R A SG10201507001R A SG 10201507001RA SG 10201507001R A SG10201507001R A SG 10201507001RA SG 10201507001R A SG10201507001R A SG 10201507001RA
- Authority
- SG
- Singapore
- Prior art keywords
- trifluoromethyl
- pyridinamine
- pyrazolo
- pyrimidin
- ethynyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/73—Unsubstituted amino or imino radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic System
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
- C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic System
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/0825—Preparations of compounds not comprising Si-Si or Si-cyano linkages
- C07F7/083—Syntheses without formation of a Si-C bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161542837P | 2011-10-04 | 2011-10-04 | |
| US201261684181P | 2012-08-17 | 2012-08-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201507001RA true SG10201507001RA (en) | 2015-10-29 |
Family
ID=46963723
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201507001RA SG10201507001RA (en) | 2011-10-04 | 2012-10-01 | Methods for the preparation of 5-[2-[7-(trifluoromethyl)-5-[4-(trifluoromethyl)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]ethynyl]-2-pyridinamine |
| SG2014014203A SG2014014203A (en) | 2011-10-04 | 2012-10-01 | Methods for the preparation of 5-[2-[7-(trifluoromethyl)-5-[4-(trifluoromethyl)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]ethynyl]-2-pyridinamine |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG2014014203A SG2014014203A (en) | 2011-10-04 | 2012-10-01 | Methods for the preparation of 5-[2-[7-(trifluoromethyl)-5-[4-(trifluoromethyl)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]ethynyl]-2-pyridinamine |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US9447099B2 (en) |
| EP (1) | EP2763991B1 (en) |
| JP (1) | JP2014532058A (en) |
| KR (1) | KR20140071474A (en) |
| CN (1) | CN103857679A (en) |
| AR (1) | AR088098A1 (en) |
| AU (1) | AU2012320732A1 (en) |
| BR (1) | BR112014007850A2 (en) |
| CA (1) | CA2847092A1 (en) |
| IL (1) | IL231283A0 (en) |
| MX (1) | MX2014004062A (en) |
| RU (1) | RU2630700C2 (en) |
| SG (2) | SG10201507001RA (en) |
| WO (1) | WO2013050310A1 (en) |
| ZA (1) | ZA201401398B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3134089A2 (en) * | 2014-04-23 | 2017-03-01 | F. Hoffmann-La Roche AG | Mglu2/3 antagonists for the treatment of intellectual disabilities |
| RU2745738C1 (en) * | 2019-05-20 | 2021-03-31 | МэбПлекс Интернэшнл Ко., Лтд. | One-reactor method for obtaining an antibody-drug conjugate intermediate product |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA05013233A (en) | 2003-06-12 | 2006-03-09 | Hoffmann La Roche | Heteroaryl-substituted imdazole derivatives as glutamate receptor antagonists. |
| US7329662B2 (en) * | 2003-10-03 | 2008-02-12 | Hoffmann-La Roche Inc. | Pyrazolo-pyridine |
| PL1725544T3 (en) * | 2004-03-09 | 2009-10-30 | Boehringer Ingelheim Pharmaceuticals Inc | 3-[4-heterocyclyl-1,2,3-triazol-1-yl]-n-aryl-benzamides as inhibitors of the cytokines production for the treatment of chronic inflammatory diseases |
| JP4708438B2 (en) * | 2005-02-11 | 2011-06-22 | エフ．ホフマン−ラ ロシュ アーゲー | Pyrazolopyrimidine derivatives as mGluR2 antagonists |
| RU2412943C2 (en) | 2005-03-23 | 2011-02-27 | Ф. Хоффманн-Ля Рош Аг | ACETYLENYL-PYRAZOLE-PYRIMIDINE DERIVATIVES AS mGluR2 ANTAGONISTS |
| ATE463495T1 (en) * | 2005-09-27 | 2010-04-15 | Hoffmann La Roche | OXADIAZOLYLPYRAZOLOPYRIMIDINES AS MGLUR2 ANTAGONISTS |
| AR074231A1 (en) * | 2008-11-27 | 2010-12-29 | Boehringer Ingelheim Int | DERIVATIVES OF 6, 7, 8, 9-TETRAHIDRO-5H-1, 4, 7, 10A-TETRAAZA-CICLOHEPT [F] INDENO, PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS, THEIR USE IN THE 5-HT2C RECEPTOR AGONISM AND PROCESSES FOR PREPARE THEM. |
| WO2011014520A2 (en) * | 2009-07-29 | 2011-02-03 | Irm Llc | Compounds and compositions as modulators of gpr119 activity |
-
2012
- 2012-09-27 US US13/628,069 patent/US9447099B2/en not_active Expired - Fee Related
- 2012-10-01 SG SG10201507001RA patent/SG10201507001RA/en unknown
- 2012-10-01 CN CN201280048837.2A patent/CN103857679A/en active Pending
- 2012-10-01 CA CA2847092A patent/CA2847092A1/en not_active Abandoned
- 2012-10-01 SG SG2014014203A patent/SG2014014203A/en unknown
- 2012-10-01 EP EP12766655.0A patent/EP2763991B1/en not_active Not-in-force
- 2012-10-01 MX MX2014004062A patent/MX2014004062A/en unknown
- 2012-10-01 AU AU2012320732A patent/AU2012320732A1/en not_active Abandoned
- 2012-10-01 JP JP2014533842A patent/JP2014532058A/en active Pending
- 2012-10-01 BR BR112014007850A patent/BR112014007850A2/en active Search and Examination
- 2012-10-01 RU RU2014116885A patent/RU2630700C2/en not_active IP Right Cessation
- 2012-10-01 KR KR1020147011727A patent/KR20140071474A/en not_active Application Discontinuation
- 2012-10-01 WO PCT/EP2012/069303 patent/WO2013050310A1/en active Application Filing
- 2012-10-02 AR ARP120103667A patent/AR088098A1/en unknown
-
2014
- 2014-02-24 ZA ZA2014/01398A patent/ZA201401398B/en unknown
- 2014-03-03 IL IL231283A patent/IL231283A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US9447099B2 (en) | 2016-09-20 |
| RU2630700C2 (en) | 2017-09-12 |
| BR112014007850A2 (en) | 2017-04-18 |
| CA2847092A1 (en) | 2013-04-11 |
| NZ621156A (en) | 2016-01-29 |
| SG2014014203A (en) | 2014-05-29 |
| KR20140071474A (en) | 2014-06-11 |
| EP2763991A1 (en) | 2014-08-13 |
| JP2014532058A (en) | 2014-12-04 |
| IL231283A0 (en) | 2014-04-30 |
| RU2014116885A (en) | 2015-11-10 |
| CN103857679A (en) | 2014-06-11 |
| US20130085278A1 (en) | 2013-04-04 |
| EP2763991B1 (en) | 2016-12-28 |
| ZA201401398B (en) | 2017-04-26 |
| AU2012320732A1 (en) | 2014-02-27 |
| AR088098A1 (en) | 2014-05-07 |
| WO2013050310A1 (en) | 2013-04-11 |
| MX2014004062A (en) | 2014-06-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LTPA2021504I1 (en) | 5-Phenyl- [1,2,4] triazolo [1,5-a] pyridin-2-yl carboxamides as JAK inhibitors | |
| IL291489A (en) | Preparation of (s)-4-(8-amino-3-(1-but-2-ynoylpyrrolidin-2-yl) imidazo [1,5-a]pyrazin-1-yl)-n-(pyridin-2-yl)benzamide and pharmaceutically acceptable salts thereof | |
| IL220921B (en) | Camsylate salt of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5- tetrahydro-6h-azepino[5,4,3-cd]indol-6-one | |
| EP2608669A4 (en) | NOVEL PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS | |
| IL228158A0 (en) | 6,7-dihydro-pyrazolo[1,5-a]pyrazin-4-ylamine derivatives useful as inhibitors of beta-secretase (bace) | |
| ZA201306719B (en) | 3,4-dihydro-pyrrolo[1,2-a]pyrazin-1-ylamine derivatives useful as inhibitors of beta-secretase (bace) | |
| EP2525659A4 (en) | PYRAZOLO[1,5-a]PYRIMIDINE COMPOUNDS AS mTOR INHIBITORS | |
| SG11201402197UA (en) | [1, 2, 3] triazolo [4, 5 -d] pyrimidine derivatives as agonists of the cannabinoid receptor 2 | |
| EP2739627A4 (en) | 2,3-dihydroimidazo[1,2-c]pyrimidin-5(1h)-one compounds use as lp-pla² inhibitors | |
| IL229993A0 (en) | Process for the preparation of 5-substituted - 8 - alkoxy [1,2,4] triazolo[1,5-c] pyrimidin-2-amines | |
| EP2580217A4 (en) | 6-(ethynyl)pyrido[2,3-d]pyrimidin-7(8h)-ones for the treatment of cns disorders | |
| ZA201403441B (en) | [1,2,3]triazolo[4,5-d]pyrimidine derivatives as agonists of the cannabinoid | |
| BR112012016786A2 (en) | Processes for preparing 7-methyl-5- (3-piperazin-1-ylmethyl- [1,2,4] oxadiazol-5-yl) -2- (4-trifluoromethoxybenzyl) -2 | |
| IL231283A0 (en) | Methods for the preparation of 5 - [2 - [7 - (trifluoromethyl) - 5 - [4 - (trifluoromethyl) phenyl] pyrazolo [1, 5-a] pyrimidin - 3 - yl] ethynyl] - 2 - pyridinamine | |
| PL395783A1 (en) | 1,2,4-triazolo [3,4-b] -1,3,4-thiadiazole - 3- (3-chlorophenyl) -6- (4-chlorophenyl) amino- [1,2,4] triazolo [derivative] 3,4-b] -1,3,4-thiadiazole, the method of its preparation and its first medical application | |
| PL395784A1 (en) | New 1,2,4-triazolo [3,4-b] -1,3,4-thiadiazole-3- (3-chlorophenyl) -6- (4-bromophenyl) amino-1,2,4-triazolo [ 3,4-b] -1,3,4-thiadiazole, the method of its preparation and its first medical application | |
| PL394218A1 (en) | New compounds, derivatives of pyrido [2'',3'':5', 6'] pyrazino [2', 3':5,6] [1,4]ditiino[2,3-b]quinoxaline and process for the preparation thereof |